Moderna Q4 2023 Earnings Financial Results

Moderna presented fourth quarter and full year 2023 financial results on February 22, 2024, covering 2023 business performance, financial metrics, 2024 priorities, and R&D/clinical programs. The presentation includes forward-looking statements regarding 2024 revenue outlook, RSV vaccine approval and launch timelines, and anticipated milestones for the company's pipeline programs over the next five years.